Inactive Instrument

News Clarmin Explorations Inc. Toronto S.E.

Equities

CYBN

CA23256X1006

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Cybin to Participate in the Alliance Global Partners Healthcare Company Showcase	05-14	BU
Cybin Provides Corporate Update and Highlights Upcoming Clinical Milestones	05-07	AQ
Cybin Provides Corporate Update and Highlights Upcoming Clinical Milestones	05-06	BU
Cybin Provides Corporate Provides Update Highlighting Recent Clinical Accomplishments and Key Upcoming Catalysts Across Its Development Pipeline	05-06	CI
Cybin to Participate at the 27th Annual Milken Institute Global Conference	04-25	BU
Cybin Announces Publication of Research Manuscript in the Journal of Medicinal Chemistry	04-18	BU
Numinus Wellness Brief: Says Cedar Clinical Research Selected as clinical research site for Cybin's Phase 3 Study of CYB003	04-17	MT
Cybin Secures US Patent for CYB003 Program in Major Depressive Disorder Treatment	04-16	MT
Cybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Breakthrough Therapy Program for Major Depressive Disorder	04-16	BU
Cybin to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	04-10	BU
Cybin : MATERIAL CHANGE REPORT - Form 6-K	03-22	PU
Cybin : AGENCY AGREEMENT - Form 6-K	03-21	PU
Cybin Inc. announced that it has received $150 million in funding from a group of investors	03-18	CI
Cybin to Present at Public Ventures Discovery Day on March 19th in Dallas	03-18	BU
Sector Update: Health Care Stocks Softer Friday Afternoon	03-15	MT
Cybin Starts Phase 2 Proof-of-Concept Study in Generalized Anxiety Disorder	03-15	MT
Cybin Initiates Phase 2 Proof-of-Concept Study of CYB004 in Generalized Anxiety Disorder	03-15	BU
Cybin Inc. Initiates Phase 2 Proof-Of-Concept Study of Cyb004 in Generalized Anxiety Disorder	03-15	CI
Discovering Promising Tech Stocks: QBTS, GEVI, CYBN, RSCI, CLRO	03-15	AQ
Cybin Reaches Alignment With FDA on Late-Stage Design For Major Depressive Disorder Trial	03-14	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Clarmin Explorations Inc. Toronto S.E.

Equities

CYBN

CA23256X1006

Summary

Filters